Spherix Global Insights
Advertising Networks · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
760 Constitution Dr Ste 204, Exton, Penn...Phone Number
(484) 879-4284Revenue
$15.4 MillionIndustry
About Spherix Global Insights
Spherix Global Insights Org Chart
Is Spherix Global Insights your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Spherix Global Insights recently announced quarterly report
Check out if Spherix Global Insights is spiking on competitors!
Click to see if Spherix Global Insights had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Spherix Global Insights has new funding data
Congratulate Masked Content for being promoted to Masked Content at Spherix Global Insights
Check if Spherix Global Insights has recently received funding, and reach out quickly before it becomes old news!
Spherix Global Insights, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Spherix Global Insights launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Spherix Global Insights
Compare insights from companies similar to Spherix Global Insights, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Spherix Global Insights is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Spherix Global Insights is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Spherix Global Insights.
Spherix Global Insights Tech Stack
A closer look at the technologies used by Spherix Global Insights
Most Recent Scoops
Spherix Global Insights News & Media
As Sickle Cell Innovation Accelerates, Hematologists Signal Demand for a Broader Treatment Arsenal Beyond Gene Therapy
New Spherix Global Insights research finds mitapivat (Agios) has surged to the top of hematologists’ most desired SCD pipeline therapies, as enthusiasm grows for both oral disease-modifying agents and potentially transformative gene therapies. New Spherix Global Insights research finds mitapivat (Agios) has surged to the top of hematologists’ most desired SCD pipeline therapies, as enthusiasm grows for both oral disease-modifying agents and potentially transformative gene therapies.Spherix Global Insights Finds One-Third of Treated MASH Patients Remain Inadequately Controlled Even as Prescription Use Expands
Physicians favor longer trials and therapy augmentation, while tailored combination use signals greater complexity once new options enter the market. Physicians favor longer trials and therapy augmentation, while tailored combination use signals greater complexity once new options enter the market.Bimzelx Momentum Builds as Rheumatologists Look Beyond TNFs to the Next Wave of axSpA Therapies, According to Spherix Global Insights
Rheumatologists report growing confidence in and use of UCB’s Bimzelx, even as broader unmet needs in axSpA drive interest in emerging agents such as tulisokibart, sonelokimab, and filgotinib. Rheumatologists report growing confidence in and use of UCB’s Bimzelx, even as broader unmet needs in axSpA drive interest in emerging agents such as tulisokibart, sonelokimab, and filgotinib.Gene Therapy Remains Top-of-Mind in Hemophilia Despite Recent Market Contraction, as Physicians and Patients Raise the Bar for Success
Nearly nine in ten EU4+UK hematologists now require longer-term efficacy data before referring patients with hemophilia A for gene therapy, while Spherix patient research reveals continued interest in the modality. Nearly nine in ten EU4+UK hematologists now require longer-term efficacy data before referring patients with hemophilia A for gene therapy, while Spherix patient research reveals continued interest in the modality.
Top Advertising Networks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Spherix Global Insights
Spherix Global Insights is a hyper-focused market intelligence firm that leverages the company's own independent data and expertise to provide strategic guidance, so biopharma stakeholders make decisions with confidence. The company specializes in select dermatology, gastroenterology, nephrology, neurology, and rheumatology markets.... Read More
